Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
50.0%
% of PPH's 27 holdings also in IHE
32.4%
% of IHE's 38 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.9% | 22.7% | 11.9% |
|
JOHNSON & JOHNSON | 6.6% | 22.8% | 6.6% |
|
ZOETIS INC | 4.6% | 4.6% | 4.6% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% | 4.6% | 4.5% |
|
PFIZER INC | 4.4% | 4.5% | 4.4% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to IHE
|
ABBVIE INC | 6.5% |
 |
NOVARTIS AG-ADR | 5.2% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.9% |
|
CENCORA INC | 4.9% |
 |
SANOFI-AVENTIS-ADR | 4.9% |
|
MCKESSON CORP | 4.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | 4.7% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.5% |
 |
TEVA PHARMACEUTICAL-SP ADR | 4.1% |
PPH Underweight Relative to IHE
|
JOHNSON & JOHNSON | -16.2% |
|
ELI LILLY & CO | -10.9% |
|
INTRA-CELLULAR THERAPIES INC | -4.6% |
|
ROYALTY PHARMA PLC CLASS A | -4.3% |
|
CORCEPT THERAPEUTICS INC | -2.1% |
|
VIATRIS, INC. | -2.0% |
|
PRESTIGE BRANDS HOLDINGS INC | -1.8% |
 |
JAZZ PHARMACEUTICALS PLC | -1.2% |
|
ELANCO ANIMAL HEALTH, INC. | -1.1% |
|
AXSOME THERAPEUTICS, INC. | -0.9% |